Phenotypic signatures of genetic frontotemporal dementia

JD Rohrer, JD Warren - Current opinion in neurology, 2011 - journals.lww.com
Phenotypic signatures of genetic frontotemporal dementia : Current Opinion in Neurology
Phenotypic signatures of genetic frontotemporal dementia : Current Opinion in Neurology Log in …

G-protein-coupled receptors in CNS: a potential therapeutic target for intervention in neurodegenerative disorders and associated cognitive deficits

S Azam, ME Haque, M Jakaria, SH Jo, IS Kim, DK Choi - Cells, 2020 - mdpi.com
Neurodegenerative diseases are a large group of neurological disorders with diverse
etiological and pathological phenomena. However, current therapeutics rely mostly on …

[HTML][HTML] Phenotypic heterogeneity of monogenic frontotemporal dementia

A Benussi, A Padovani, B Borroni - Frontiers in aging neuroscience, 2015 - frontiersin.org
Frontotemporal dementia (FTD) is a genetically and pathologically heterogeneous disorder
characterized by personality changes, language impairment, and deficits of executive …

Molecular imaging to track Parkinson's disease and atypical parkinsonisms: new imaging frontiers

AP Strafella, NI Bohnen, JS Perlmutter… - Movement …, 2017 - Wiley Online Library
Molecular imaging has proven to be a powerful tool for investigation of parkinsonian
disorders. One current challenge is to identify biomarkers of early changes that may predict …

The role of GPCRs in neurodegenerative diseases: avenues for therapeutic intervention

Y Huang, N Todd, A Thathiah - Current opinion in pharmacology, 2017 - Elsevier
Highlights•GPCRs are implicated in the pathophysiology of various neurodegenerative
diseases.•Currently available therapies do not cure the discussed neurodegenerative …

Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study

HJMM Mutsaerts, SS Mirza, J Petr, DL Thomas… - Brain, 2019 - academic.oup.com
Genetic forms of frontotemporal dementia are most commonly due to mutations in three
genes, C9orf72, GRN or MAPT, with presymptomatic carriers from families representing …

Psychosis and hallucinations in frontotemporal dementia with the C9ORF72 mutation: a detailed clinical cohort

A Kertesz, LC Ang, S Jesso, J MacKinley… - Cognitive and …, 2013 - journals.lww.com
Objective: To specify the presenting symptoms and clinical course of patients with
frontotemporal dementia (FTD) and chromosome 9 open reading frame 72 (C9ORF72) …

Early-onset dementias: diagnostic and etiological considerations

M Masellis, K Sherborn, PR Neto, DA Sadovnick… - Alzheimer's Research & …, 2013 - Springer
This paper summarizes the body of literature about early-onset dementia (EOD) that led to
recommendations from the Fourth Canadian Consensus Conference on the Diagnosis and …

Parkinsonism and frontotemporal dementia: the clinical overlap

AJ Espay, I Litvan - Journal of Molecular Neuroscience, 2011 - Springer
Frontotemporal dementia is commonly associated with parkinsonism in several sporadic (ie,
progressive supranuclear palsy, corticobasal degeneration) and familial neurodegenerative …

Neuroprotective effects of progranulin in ischemic mice

J Tao, F Ji, F Wang, B Liu, Y Zhu - Brain research, 2012 - Elsevier
Progranulin (PGRN) is a widely expressed protein with diverse biological functions. We
generated a transgenic mouse overexpressing PGRN and found significantly elevated …